Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IntraTherapeutics IntraCoil PMA Foiled By Widespread Off-Label Stenting

This article was originally published in The Gray Sheet

Executive Summary

Sulzer/IntraTherapeutics said it will continue efforts to win FDA approval of its IntraCoil stent for use in the popliteal and femoral arteries, despite the rampant off-label use of other stents for the indication.

You may also be interested in...



FDA Rounds Up Biliary Stent Makers On Off-label Promotion

FDA gathered biliary stent manufacturers to discuss how to prevent off-label marketing for peripheral vascular disease while it clarifies the regulatory pathway for vascular stents

FDA Rounds Up Biliary Stent Makers On Off-label Promotion

FDA gathered biliary stent manufacturers to discuss how to prevent off-label marketing for peripheral vascular disease while it clarifies the regulatory pathway for vascular stents

FDA Defers To Expert Panel For Peripheral DES Guidance Development

Expert group consensus guidelines for preclinical studies and evaluation of peripheral drug-eluting stents will be available for public comment by early March

Related Content

UsernamePublicRestriction

Register

MT014810

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel